Search - tctmd.com

Displaying 21 - 40 of 51

Sort: Relevancy | Date

News Daily News

Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data

L.A. McKeown

July 31, 2018

Story 2: STS Data: Mitral Valve Cases Are Fastest-Growing Surgical Intervention in North America

News Daily News

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

L.A. McKeown

July 25, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

Presentation

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

July 11, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Percutaneous VA ECMO Supported Transcatheter Valve-in-Valve Implantation for Severe Bioprosthetic Pulmonic Valve Dysfunction Using Moderate Sedation in the Cardiac Catheterization Laboratory

Presenter: Isaac George, Christopher U. Meduri, Gautam Visveswaran, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

TCT 8: Aortic Paravalvular Amplatzer Plug Extractions, Valve in Valve TAVR and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presentation The Structural Heart Disease Summit 2018

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presenter: Ashish Pershad, Mehul Patel

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presenter: Ashish Pershad, Mehul Patel

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Advertisement

Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Percutaneous VA ECMO Supported Transcatheter Valve-in-Valve Implantation for Severe Bioprosthetic Pulmonic Valve Dysfunction Using Moderate Sedation in the Cardiac Catheterization Laboratory

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Case #3: A Small (Undersized) Surgical Bioprosthesis

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Case #1: A Poorly Visible Surgical Bioprosthesis

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content